-
Categories
-
Pharmaceutical Intermediates
-
Active Pharmaceutical Ingredients
-
Food Additives
- Industrial Coatings
- Agrochemicals
- Dyes and Pigments
- Surfactant
- Flavors and Fragrances
- Chemical Reagents
- Catalyst and Auxiliary
- Natural Products
- Inorganic Chemistry
-
Organic Chemistry
-
Biochemical Engineering
- Analytical Chemistry
-
Cosmetic Ingredient
- Water Treatment Chemical
-
Pharmaceutical Intermediates
Promotion
ECHEMI Mall
Wholesale
Weekly Price
Exhibition
News
-
Trade Service
The production of (S)-1-(5-phenyl-1H-imidazol-2-yl)ethanamine, also known as Remazol-R, is a complex process that involves several steps and requires specialized equipment and conditions.
In this article, we will take a detailed look at the production process of Remazol-R, which is widely used as a pharmaceutical intermediate, a catalyst, and a research tool.
Step 1: Synthesis of N-Boc-N-Methyl-N-(1,5-phenyl-1H-imidazol-2-yl)acetamide
The first step in the production of Remazol-R involves the synthesis of N-Boc-N-methyl-N-(1,5-phenyl-1H-imidazol-2-yl)acetamide, which is a crucial intermediate.
This can be accomplished using a variety of methods, but the most common approach is via a two-step reaction using 1,5-phenyl-1H-imidazole and acetic anhydride in the presence of a base, such as sodium hydroxide.
The reaction is typically carried out in a solvent, such as toluene or acetonitrile, and the product is then isolated using standard techniques, such as precipitation or filtration.
Step 2: Boc Protecting Group Removal
The next step involves the removal of the Boc protecting group from the intermediate obtained in step 1.
This can be accomplished using a variety of techniques, but the most common approach is via hydrolysis with a strong acid, such as hydrochloric acid, in the presence of a solvent, such as ethyl acetate.
The product is then isolated using standard techniques, such as precipitation or filtration.
Step 3: Reductive Amination
The next step involves the reduction of the nitro group of the intermediate obtained in step 2 to form the primary amine.
This can be accomplished using a variety of reducing agents, such as lithium aluminum hydride (LiAlH4) or hydrogen in the presence of a catalyst, such as palladium on barium sulfate.
The reaction is typically carried out in a solvent, such as THF or DMF, and the product is then isolated using standard techniques, such as precipitation or filtration.
Step 4: Deprotection
The final step involves the deprotection of the intermediate obtained in step 3 to form the final product, (S)-1-(5-phenyl-1H-imidazol-2-yl)ethanamine.
This can be accomplished using a variety of approaches, but the most common approach is via hydrolysis with a strong acid, such as hydrochloric acid, in the presence of a solvent, such as ethyl acetate.
The product is then isolated using standard techniques, such as precipitation or filtration.
Overall, the production process of Remazol-R involves several steps, including the synthesis of N-Boc-N-methyl-N-(1,5-phenyl-1H-imidazol-2-yl)acetamide, the removal of the Boc protecting group, the reduction of the nitro group to form the primary amine, and the deprotection of the final product.
Each step requires careful control of conditions and the use of specialized equipment to ensure the production of a high-quality product.
The final product is then typically purified and characterized to ensure its identity and purity.